Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
SIMCAP
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
- NCT03456843 ↗
- Active, not recruiting
- Yale University
- Focused
We haven't built an HCP commentary report on SIMCAP (newly diagnosed metastatic prostate cancer; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on SIMCAP so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Stage IV Prostate Adenocarcinoma AJCC v7
- Interventions
- Antiandrogen Therapy; Docetaxel; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration; Radical Prostatectomy
- Arms
- Arm I (Control Group) · Experimental
- Arm II (Experimental) · Experimental
- Enrollment
- 190 (estimated)
- Primary outcomes
- Failure-free survival (FFS)
- Sponsor
- Yale University with National Cancer Institute (NCI)
- Start
- Mar 20, 2018
- Primary completion
- Mar 2027 (estimated)
- Results posted
- No
- Registry record
- NCT03456843 · updated Jul 24, 2026